project id: TCGA-COAD; case submitter id: TCGA-D5-6927; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; age at index: 34; days to birth: -12737; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1977; age at diagnosis: 12737; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 287.0; icd 10 code: C18.7; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Sigmoid colon; synchronous malignancy: No; tissue or organ of origin: Sigmoid colon; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.9; longest dimension: 2.5; oct embedded: No; shortest dimension: 0.5; portion submitter id: TCGA-D5-6927-01A-21; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 2.0; percent necrosis: 12.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 21.0; percent tumor cells: 67.0; percent tumor nuclei: 75.0;